The DOI matches its Crossref record; 347 of the 347 references it cites were found in a registry or an index.
Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†
Open accessAbstract
The Working Party makes more than 100 tabulated recommendations in antimicrobial prescribing for the treatment of infections caused by multidrug-resistant (MDR) Gram-negative bacteria (GNB) and suggest further research, and algorithms for hospital and community antimicrobial usage in urinary infection. The international definition of MDR is complex, unsatisfactory and hinders the setting and monitoring of improvement programmes. We give a new definition of multiresistance. The background information on the mechanisms, global spread and UK prevalence of antibiotic prescribing and resistance has been systematically reviewed. The treatment options available in hospitals using intravenous antibiotics and in primary care using oral agents have been reviewed, ending with a consideration of antibiotic stewardship and recommendations. The guidance has been derived from current peer-reviewed publications and expert opinion with open consultation. Methods for systematic review were NICE compliant and in accordance with the SIGN 50 Handbook; critical appraisal was applied using AGREE II. Published guidelines were used as part of the evidence base and to support expert consensus. The guidance includes recommendations for stakeholders (including prescribers) and antibiotic-specific recommendations. The clinical efficacy of different agents is critically reviewed. We found there are very few good-quality comparative randomized clinical trials to support treatment regimens, particularly for licensed older agents. Susceptibility testing of MDR GNB causing infection to guide treatment needs critical enhancements. Meropenem- or imipenem-resistant Enterobacteriaceae should have their carbapenem MICs tested urgently, and any carbapenemase class should be identified: mandatory reporting of these isolates from all anatomical sites and specimens would improve risk assessments. Broth microdilution methods should be adopted for colistin susceptibility testing. Antimicrobial stewardship programmes should be instituted in all care settings, based on resistance rates and audit of compliance with guidelines, but should be augmented by improved surveillance of outcome in Gram-negative bacteraemia, and feedback to prescribers. Local and national surveillance of antibiotic use, resistance and outcomes should be supported and antibiotic prescribing guidelines should be informed by these data. The diagnosis and treatment of both presumptive and confirmed cases of infection by GNB should be improved. This guidance, with infection control to arrest increases in MDR, should be used to improve the outcome of infections with such strains. Anticipated users include medical, scientific, nursing, antimicrobial pharmacy and paramedical staff where they can be adapted for local use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–347 of 347
Sader, H. S., Castanheira, M., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02429-13 · Cited by 129
Risk of AKI with Gentamicin as Surgical Prophylaxis
Bell, S., Davey, P. G., Nathwani, D., Marwick, C., Vadiveloo, T., Sneddon, J., Patton, A., Bennie, M., Fleming, S., & Donnan, P. T. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010035 · Cited by 125
Castanheira, M., Mills, J. C., Costello, S. E., Jones, R. N., & Sader, H. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00163-15 · Cited by 123
McNulty, C. A. M., Richards, J., Livermore, D. M., Little, P. S., Charlett, A., Freeman, E., Harvey, I. M., & Thomas, M. D. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl368 · Cited by 121
Self-citationCalil, R., Marba, S. T. M., von NOWAKONSKI, A., & Tresoldi, A. T. (2001) · American Journal of Infection Control · doi:10.1067/mic.2001.114223 · Cited by 120
Koomanachai, P., Tiengrim, S., Kiratisin, P., & Thamlikitkul, V. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.09.011 · Cited by 119
Endimiani, A., Hujer, K. M., Hujer, A. M., Armstrong, E. S., Choudhary, Y., Aggen, J. B., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00556-09 · Cited by 118
Crandon, J. L., Schuck, V., Banevicius, M. A., Beaudoin, M., Nichols, W. W., Tanudra, M. A., & Nicolau, D. P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00851-12 · Cited by 118
Walkty, A. J., Adam, H. J., Baxter, M. R., Denisuik, A. J., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., & Zhanel, G. G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02744-13 · Cited by 116
Chopra, T., Marchaim, D., Veltman, J., Johnson, P., Zhao, J. J., Tansek, R., Hatahet, D., Chaudhry, K., Pogue, J. M., Hiro, R., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05419-11 · Cited by 115
Yong, M. K., Buising, K. L., Cheng, A. C., & Thursky, K. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq058 · Cited by 115
Vardakas, K. Z., Tansarli, G. S., Bliziotis, I. A., & Falagas, M. E. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.12.006 · Cited by 115
Ipe, D. S., Sundac, L., Benjamin, W. H., Moore, K. H., & Ulett, G. C. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12204 · Cited by 113
Endimiani, A., Luzzaro, F., Perilli, M., Lombardi, G., Coli, A., Tamborini, A., Amicosante, G., & Toniolo, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380645 · Cited by 112
Tanaseanu, C. M., Bergallo, C., Teglia, O., Jasovich, A., Oliva, M. E., Dukart, G., Dartois, N., Cooper, C. A., Gandjini, H., & Mallick, R. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.04.009 · Cited by 112
Balakrishnan, I., Awad-El-Kariem, F. M., Aali, A., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr317 · Cited by 111
Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014
Bou-Antoun, S., Davies, J., Guy, R. L., Johnson, A. P., Sheridan, E., & Hope, R. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.35.30329 · Cited by 111
Tam, V. H., Gamez, E. A., Weston, J. S., Gerard, L. N., LaRocco, M., Caeiro, J. P., Gentry, L. O., & Garey, K. W. (2008) · Clinical Infectious Diseases · doi:10.1086/528712 · Cited by 110
Fosfomycin Susceptibility in Carbapenem-Resistant Enterobacteriaceae from Germany
Kaase, M., Szabados, F., Anders, A., & Gatermann, S. G. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03484-13 · Cited by 109
Hornsey, M., Loman, N. J., Wareham, D. W., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr168 · Cited by 109
Abernethy, J., Guy, R. L., Sheridan, E. A. S., Hopkins, S., Kiernan, M., Wilcox, M. H., Johnson, A. P., Hope, R., Sen, R. A., Mifsud, A., et al. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.12.008 · Cited by 109
Aldeyab, M. A., Harbarth, S., Vernaz, N., Kearney, M. P., Scott, M., Elhajji, F. D., Aldiab, M. A., & McElnay, J. C. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04161.x · Cited by 106
Forgotten Antibiotics: An Inventory in Europe, the United States, Canada, and Australia
Pulcini, C., Bush, K., Craig, W. A., Møller, J. K., Grayson, M. L., Mouton, J. W., Turnidge, J. D., Harbarth, S., Gyssens, I. C., & the ESCMID Study Group for Antibiotic Policies (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir838 · Cited by 105
González-Padilla, M., Torre‐Cisneros, J., Rivera-Espinar, F., Pontes-Moreno, A., López‐Cerero, L., Pascual, Á., Natera, C., Rodriguez, M., Salcedo-Leal, I., Rodríguez-López, F., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku432 · Cited by 104
Thulin, E., Sundqvist, M., & Andersson, D. I. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04819-14 · Cited by 103
Global Incidence of Carbapenemase-ProducingEscherichia coliST131
Peirano, G., Bradford, P. A., Kazmierczak, K. M., Badal, R. E., Hackel, M., Hoban, D. J., & Pitout, J. D. D. (2014) · Emerging infectious diseases · doi:10.3201/eid2011.141388 · Cited by 103
Shapiro, M., Simchen, E., Izraeli, S., & Sacks, T. (1984) · Infection Control · doi:10.1017/s019594170006104x · Cited by 103
Mora, A., Herrera, A., Mamani, R. C., López, C., Alonso, M. P., Blanco, J. E., Blanco, M., Dahbi, G., Garcı́a-Garrote, F., Pita, J., et al. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.01112-10 · Cited by 103
Gatell, J. M., Ferran, F., Araujo, V., Bonet, M., Soriano, E., Traserra, J., & SanMiguel, J. G. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.9.1383 · Cited by 101
Barbolla, R. E., Catalano, M., Orman, B. E., Famiglietti, A. M. R., Vay, C. A., Smayevsky, J., Centrón, D., & Piñeiro, S. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.666-669.2004 · Cited by 100
López-Cortés, L. F., Cisneros, J. M., Fernández-Cuenca, F., Bou, G., Tomás, M., Garnacho‐Montero, J., Pascual, Á., Martı́nez-Martı́nez, L., Vilà, J., Pachón, J., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku233 · Cited by 100
Aminoglycoside resistance in gram-negative bacilli during increased amikacin use
Gerding, D. N., & Larson, T. A. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90184-6 · Cited by 99
Oteo, J., Orden, B., Bautista, V., Cuevas, Ó., Arroyo, M., Martínez-Ruiz, R., Pérez-Vázquez, M. D., Alcaraz, M., García-Cobos, S., & Campos, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp288 · Cited by 99
Systematic Review of Risk Factors for Urinary Tract Infection in Adults with Spinal Cord Dysfunction
Shekelle, P., Morton, S. C., Clark, K. A., Pathak, M. S., & Vickrey, B. G. (1999) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.1999.11719579 · Cited by 98
Kalın, G., Alp, E., Akin, A., Coskun, R., & Doğanay, M. (2013) · Infection · doi:10.1007/s15010-013-0495-y · Cited by 97
Lupo, A., Papp‐Wallace, K. M., Sendi, P., Bonomo, R. A., & Endimiani, A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.06.001 · Cited by 95
Ho, P., Chan, J., Lo, W.-U., Lai, E. L.-Y., Cheung, Y., Lau, T. C., & Chow, K. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.062653-0 · Cited by 95
Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis
Zhanel, G. G., Walkty, A. J., & Karlowsky, J. A. (2016) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2016/2082693 · Cited by 95
International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review
Hassing, R. J., Alsma, J., Arcilla, M. S., van Genderen, P. J. J., Stricker, B. H. C., & Verbon, A. (2015) · Eurosurveillance · doi:10.2807/1560-7917.es.2015.20.47.30074 · Cited by 94
Laterre, P., Wittebole, X., de Velde, S. V., Muller, A. E., Mouton, J. W., Carryn, S., Tulkens, P. M., & Dugernier, T. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku465 · Cited by 93
Lew, K. Y., Ng, T. M., Tan, M., Tan, S. H., Lew, E. L., Ling, L. M., Ang, B. S. P., Lye, D. C., & Teng, C. B. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku479 · Cited by 92
Peralta, G., Lamelo, M., Álvarez-García, P., Velasco, M., Delgado, A., Horcajada, J. P., Montero, M., Mesones, M. P. R., Fariñas, M. C., Alonso, J. D., et al. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-245 · Cited by 91
Kahlmeter, G., Åhman, J., & Matuschek, E. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0095-5 · Cited by 90
Latibeaudiere, R., Rosa, R. M., Laowansiri, P., Arheart, K. L., Namias, N., & Munoz-Price, L. S. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu847 · Cited by 90
Nguyen, H. M., Shier, K. L., & Graber, C. J. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt450 · Cited by 90
Fournier, D., Richardot, C., Müller, E., Robert-Nicoud, M., Llanes, C., Plésiat, P., & Jeannot, K. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt098 · Cited by 90
Sader, H. S., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.04.004 · Cited by 88
Ceccarelli, G., Falcone, M., Giordano, A., Mezzatesta, M. L., Caio, C., Stefani, S., & Venditti, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00188-13 · Cited by 88
Wang, X., Zhang, F., Zhao, C., Wang, Z., Nichols, W. W., TESTA, R. T., Li, H., Chen, H., He, W., Wang, Q., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02123-13 · Cited by 88
Retamar, P., López‐Cerero, L., Muniain, M. A., Pascual, Á., Rodríguez‐Baño, J., & the ESBL-REIPI/GEIH Group (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00135-13 · Cited by 86
Xiong, J., Alexander, D. C., Ma, J. H., Déraspe, M., Low, D. E., Jamieson, F., & Roy, P. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00423-13 · Cited by 86
The action of metronidazole on DNA
Edwards, D. (1977) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/3.1.43 · Cited by 84
Eckmann, C., Montravers, P., Bassetti, M., Bodmann, K. ‐., Heizmann, W. R., García, M. S., Guirao, X., Capparella, M. R., Simoneau, D., & Dupont, H. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt142 · Cited by 84
Sader, H. S., Castanheira, M., Mendes, R. E., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05024-14 · Cited by 83
Søraas, A. V. L., Sundsfjord, A., Jørgensen, S. B., Liestøl, K., & Jenum, P. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085889 · Cited by 83
Murray, C. K., Yun, H. C., Griffith, M. E., Thompson, B., Crouch, H. K., Monson, L. S., Aldous, W. K., Mende, K., & Hospenthal, D. R. (2009) · Military Medicine · doi:10.7205/milmed-d-03-8008 · Cited by 83
Fitzpatrick, J. M., Biswas, J. S., Edgeworth, J. D., Islam, J., Jenkins, N., Judge, R. D. M., Lavery, A. J., Melzer, M., Morris-Jones, S. D., Nsutebu, E. F., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.10.034 · Cited by 83
Lee, N., Lee, C., Li, C., Li, M.-C., Chen, P., Chang, C., & Ko, W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01477-15 · Cited by 83
Plasmid-Mediated OqxAB Is an Important Mechanism for Nitrofurantoin Resistance in Escherichia coli
Ho, P., Ng, K.-Y., Lo, W.-U., Law, P. Y.-T., Lai, E. L.-Y., Wang, Y., & Chow, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02156-15 · Cited by 82
Titelman, E., Hasan, C. M., Iversen, A., Nauclér, P., Kais, M., Kalin, M., & Giske, C. G. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12559 · Cited by 81
Maâlej, S., Méziou, M., Rhimi, F., & Hammami, A. (2011) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2011.03145.x · Cited by 80
Tängdén, T., Adler, M., Cars, O., Sandegren, L., & Löwdin, E. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt044 · Cited by 80
Livermore, D. M., Hope, R., Fagan, E. J., Warner, M., Woodford, N., & Potz, N. A. C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl043 · Cited by 79
Self-citationOplinger, M., & Andrews, C. O. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r352 · Cited by 79
Rodriguez‐Villalobos, H., Bogaerts, P., Berhin, C., Bauraing, C., Deplano, A., Montesinos, I., Mendonça, R. D., Jans, B., & Glupczynski, Y. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq388 · Cited by 78
Pea, F., Viale, P., Cojutti, P. G., & Furlanut, M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01291-12 · Cited by 78
Toltzis, P., Dul, M. J., Hoyen, C. K., Salvator, A. E., Walsh, M. C., Zetts, L., & Toltzis, H. (2002) · PEDIATRICS · doi:10.1542/peds.110.4.707 · Cited by 77
Borer, A., Eskira, S., Nativ, R., Saidel‐Odes, L., Riesenberg, K., Livshiz‐Riven, I., Schlaeffer, F., Sherf, M., & Peled, N. (2011) · Infection Control and Hospital Epidemiology · doi:10.1086/662620 · Cited by 77
Tumbarello, M., Viale, P., Bassetti, M., Rosa, F. G. D., Spanu, T., & Viscoli, C. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv200 · Cited by 76
Shen, F., Han, Q., Xie, D., Fang, M., Zeng, H., & Deng, Y. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.08.009 · Cited by 76
Dortch, M. J., Fleming, S. B., Kauffmann, R. M., Dossett, L. A., Talbot, T. R., & May, A. K. (2010) · Surgical Infections · doi:10.1089/sur.2009.059 · Cited by 76
Jenkins, A., Thomson, A. H., Brown, N. M., Semple, Y., Sluman, C., MacGowan, A. P., Lovering, A. M., & Wiffen, P. J. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw250 · Cited by 76
Parker, S. L., Lipman, J., Koulenti, D., Dimοpoulos, G., & Roberts, J. A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.05.018 · Cited by 75
NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases
Jain, A., Hopkins, K. L., Turton, J. F., Doumith, M., Hill, R., Loy, R., Meunier, D., Pike, R., Livermore, D. M., & Woodford, N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku084 · Cited by 74
Self-citationHara, G. L., Gould, I. M., Endimiani, A., Ramón-Pardo, P., Daikos, G. L., Hsueh, P., Mehtar, S., Petrikkos, G. L., Casellas, J. M., Daciuk, L., et al. (2013) · Journal of Chemotherapy · doi:10.1179/1973947812y.0000000062 · Cited by 73
Dewar, S., Reed, L. C., & Koerner, R. J. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt368 · Cited by 72
Johnson, S. W., Anderson, D. J., May, D. B., & Drew, R. H. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/669858 · Cited by 72
Jd, R. (1957) · PubMed · Cited by 72
Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?
Vasoo, S. S. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00888-17 · Cited by 72
Tetracyclines for multidrug-resistant Acinetobacter baumannii infections
Falagas, M. E., Vardakas, K. Z., Kapaskelis, A. M., Triarides, N. A., & Roussos, N. S. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.12.031 · Cited by 71
Little, P. S., Rumsby, K., Jones, R., Warner, G., Moore, M. V., Lowes, J. A., Smith, H. E., Hawke, C. I., Leydon, G., & Mullee, M. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x514747 · Cited by 71
Flamm, R. K., Farrell, D. J., Sader, H. S., & Jones, R. N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku025 · Cited by 70
Pérez, F., & Bonomo, R. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir793 · Cited by 70
Ethical dilemmas in antibiotic treatment
Leibovici, L., Paul, M., & Ezra, O. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr425 · Cited by 69
Role of cephalosporins in the era ofClostridium difficileinfection
Wilcox, M. H., Chalmers, J. D., Nord, C. E., Freeman, J., & Bouza, E. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw385 · Cited by 68
Jansåker, F., Frimodt‐Møller, N., Sjogren, I., & Knudsen, J. D. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt404 · Cited by 66
Wickramasinghe, N., Xu, L., Eustace, A., Shabir, S., Saluja, T., & Hawkey, P. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks018 · Cited by 65
Self-citationComparison of Comorbidity Collection Methods
Kallogjeri, D., Gaynor, S. M., Piccirillo, M. L., Jean, R. A., Spitznagel, E. L., & Piccirillo, J. F. (2014) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2014.01.059 · Cited by 65
Jones, G., Warren, R. E., Skidmore, S., Davies, V. A., Gibreel, T. M., & Upton, M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn406 · Cited by 65
Self-citationEscherichia coli bacteraemia: 2 years of prospective regional surveillance (2010-12)
Horner, C., Fawley, W. N., Morris, K. A., Parnell, P., Denton, M., & Wilcox, M. H. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt333 · Cited by 65
Lee, B. Y., Bartsch, S. M., Wong, K. F., McKinnell, J. A., Slayton, R. B., Miller, L. G., Cao, C., Kim, D. S., Kallen, A. J., Jernigan, J. A., et al. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv299 · Cited by 64
Park, S. H., Choi, S., Chang, Y. K., Lee, D., Cho, S., Lee, H.-J., Choi, J., & Yoo, J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku215 · Cited by 63
Tchesnokova, V. L., Billig, M., Chattopadhyay, S., Linardopoulou, E. V., Aprikian, P., Roberts, P. L., Skrivankova, V. W., Johnston, B., Gileva, A., Igusheva, I., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00984-13 · Cited by 63
Vourli, S., Dafopoulou, K., Vrioni, G., Tsakris, A., & Pournaras, S. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx186 · Cited by 61
Tamma, P. D., Newland, J. G., Pannaraj, P. S., Metjian, T. A., Banerjee, R., Gerber, J. S., Weissman, S. J., Beekmann, S. E., Polgreen, P. M., & Hersh, A. L. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182703790 · Cited by 58
Carbapenemase-Producing Klebsiella pneumoniae in Romania: A Six-Month Survey
Lixandru, B. E., Cotar, A. I., Străuţ, M., Usein, C. R., Cristea, D., Ciontea, S. A., Tatu-Chiţoiu, D., Codiţă, I., Rafilă, A., Nica, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143214 · Cited by 56
Decousser, J., Poirel, L., & Nordmann, P. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1289087 · Cited by 56
Rogers, B. A., Kennedy, K., Sidjabat, H. E., Jones, M., Collignon, P., & Paterson, D. L. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1584-z · Cited by 53
Duration of Antibacterial Treatment for Uncomplicated Urinary Tract Infection in Women
Milo, G., Katchman, E. A., Paul, M., Christiaens, T., Bærheim, A., & Leibovici, L. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00550-1 · Cited by 53
Schlackow, I., Stoesser, N. E., Walker, A. S., Crook, D. W., Peto, T., & Wyllie, D. H. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks082 · Cited by 52
Gutiérrez‐Gutiérrez, B., Bonomo, R. A., Carmeli, Y., Paterson, D. L., Almirante, B., Martínez-Martínez, L., Oliver, A., Calbo, E., Peña, C., Akova, M., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv502 · Cited by 52
Wiskirchen, D. E., Nordmann, P., Crandon, J. L., & Nicolau, D. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01947-13 · Cited by 51
Merino, I., Shaw, E., Horcajada, J. P., Cercenado, E., Mirelis, B., Pallarés, Á., Gómez, J., Xercavins, M., Martínez-Martínez, L., de Cueto, M., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw133 · Cited by 51
Monogue, M. L., Pettit, R. S., Muhlebach, M. S., Cies, J. J., Nicolau, D. P., & Kuti, J. L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01566-16 · Cited by 51
Geerts, A. F. J., Eppenga, W. L., Heerdink, E. R., Derijks, H. J., Wensing, M., Egberts, T. C. G., & Smet, P. A. G. M. D. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1520-x · Cited by 50
Goldstein, E. J. C., Citron, D. M., Peraino, V. A., Elgourt, T., Meibohm, A. R., & Lu, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00064-09 · Cited by 50
Gupta, K., Hooton, T. M., & Stamm, W. E. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki169 · Cited by 49
Chen, X., Zhang, W., Yin, J., Zhang, N., Geng, S., Zhou, X., Wang, Y., Gao, S., & Jiao, X. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.06.016 · Cited by 48
Tsai, H.-Y., Chen, Y., Tang, H.-J., Huang, C.-C., Liao, C., Chu, F., Chuang, Y.-C., Sheng, W., Ko, W., & Hsueh, P. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.07.006 · Cited by 48
Ecological effects of short-term ciprofloxacin treatment of travellers' diarrhoea
Wiström, J., Gentry, L. O., Palmgren, A., Price, M., Nord, C. E., Ljungh, Å., & Norrby, S. R. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.5.693 · Cited by 47
Edwards, S. J., Emmas, C., & Campbell, H. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x46223 · Cited by 45
Day, M. J., Doumith, M., Abernethy, J., Hope, R., Reynolds, R., Wain, J. R., Livermore, D. M., & Woodford, N. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw145 · Cited by 45
Self-citationNanotheranostic approaches for management of bloodstream bacterial infections
Jagtap, P., Sritharan, V., & Gupta, S. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.09.005 · Cited by 45
Papp‐Wallace, K. M., Bajaksouzian, S., Abdelhamed, A. M., et al. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.02.003 · Cited by 44
Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota
Vervoort, J., Xavier, B. B., Stewardson, A. J., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv062 · Cited by 44
Lampri, N., Galani, I., Poulakou, G., Katsarolis, I., Petrikkos, G. L., Giamarellou, H., & Souli, M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks215 · Cited by 43
Nord, C., Wadström, T., & Wretlind, B. (1974) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.6.4.521 · Cited by 40
Ni, W., Cai, X., Wei, C., Di, X., Cui, J., Wang, R., & Liu, Y.-N. (2015) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2014.12.004 · Cited by 40
Millán, Á. S., Toll‐Riera, M., Escudero, J. A., Cantón, R., Coque, T. M., & MacLean, R. C. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv222 · Cited by 40
Martino, R., Subirá, M., Altés, A., et al. (1998) · Acta Haematologica · doi:10.1159/000040840 · Cited by 39
Smeets, H. M., Kuyvenhoven, M. M., Schep‐Akkerman, A., Welschen, I., Schouten, G. K., van Essen, G. A., & Verheij, T. J. (2009) · Family Practice · doi:10.1093/fampra/cmp008 · Cited by 38
Pai, M. P., Cojutti, P. G., & Pea, F. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0266-2 · Cited by 37
Hall, M. L.-V., Fluit, A. C., Blok, H. E. M., Box, A. T. A., Peters, E. D. J., Weersink, A. J. L., & Verhoef, J. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960100615 · Cited by 36
Priorities in the prevention and control of multidrug-resistant Enterobacteriaceae in hospitals
Khan, A. S., Dancer, S. J., & Humphreys, H. (2012) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.06.013 · Cited by 35
Livermore, D. M., Threlfall, E. J., Reacher, M. H., et al. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.2.205 · Cited by 34
Self-citationValverde, A., Turrientes, M. C., Norman, F., Martín, E. S., Moreno, L., Pérez-Molina, J. A., López‐Vélez, R., & Cantón, R. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.09.021 · Cited by 31
Daily dosage of aminoglycosides.
Urban, A. W., & Craig, W. A. (1997) · PubMed · Cited by 31
Jitmuang, A., Nation, R. L., Koomanachai, P., Chen, G., Lee, H. J., Vasuvattakul, S., Sritippayawan, S., Li, J., Thamlikitkul, V., & Landersdorfer, C. B. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv031 · Cited by 30
Livermore, D. M., Mushtaq, S., Warner, M., & Woodford, N. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt455 · Cited by 28
Self-citationMcDougall, D. A. J., Morton, A. P., & Playford, E. G. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks385 · Cited by 25
Perez, L. R. R. (2015) · Apmis · doi:10.1111/apm.12438 · Cited by 24
Findlay, J., Hopkins, K. L., Alvarez-Buylla, A., Meunier, D., Mustafa, N., Hill, R., Pike, R., McCrae, L., Hawkey, P. M., & Woodford, N. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw560 · Cited by 24
Self-citationAntimicrobial stewardship: we know it works; time to make sure it is in place everywhere
Plachouras, D., & Hopkins, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.ed000119 · Cited by 24
Cha, M. K., Kang, C., Ys, K., Cho, S. Y., Ha, Y. E., Wi, Y. M., Chung, D. R., Peck, K. R., & Song, J. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.10.015 · Cited by 23
Nigo, M., Cevallos, C. S., Woods, K. L., Flores, V. M., Francis, G., Perlman, D. C., Revuelta, M., Mildvan, D., Waldron, M., Gomez, T., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00827-13 · Cited by 23
Melchers, M. J. B., van Mil, A. C. H. A. M., & Mouton, J. W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04498-14 · Cited by 22
Heizmann, W. R., Dupont, H., Montravers, P., Guirao, X., Eckmann, C., Bassetti, M., García, M. S., Capparella, M. R., Simoneau, D., & Bodmann, K. ‐. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt144 · Cited by 22
de Champs, C., Franchineau, P., Gourgand, J.-M., Loriette, Y., Gaulme, J., & Sirot, J. (1994) · Journal of Hospital Infection · doi:10.1016/0195-6701(94)90104-x · Cited by 20
Horner, C., Abberley, N., Denton, M., & Wilcox, M. H. (2013) · Epidemiology and Infection · doi:10.1017/s0950268813000988 · Cited by 20
Mutters, N. T., Zimmermann, S., Kaase, M., & Mischnik, A. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2498-3 · Cited by 20
Noteboom, Y., Ong, D. S. Y., Oostdijk, E. A. N., Schultz, M. J., de Jonge, E., Purmer, I. M., Bergmans, D. C. J. J., Fijen, J. W., Kesecioğlu, J., & Bonten, M. J. M. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001298 · Cited by 19
Baines, S. D., O'Connor, R., Huscroft, G. S., Saxton, K., Freeman, J., & Wilcox, M. H. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp017 · Cited by 18
Papakonstantinou, I. P., Angelopoulos, E. T., Baraboutis, I. G., Perivolioti, E., Parisi, M., Psaroudaki, Z., Kampisiouli, E., Argyrοpoulou, A., Nanas, S., & Routsi, C. (2014) · Journal of Chemotherapy · doi:10.1179/1973947814y.0000000199 · Cited by 11
Thom, K. A., Johnson, J. A., Strauss, S. M., Furuno, J. P., Perencevich, E. N., & Harris, A. D. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/522680 · Cited by 10
Park, G. E., Kang, C., Wi, Y. M., Ko, J., Lee, W. J., Lee, J., Cho, S. Y., Ha, Y. E., Chung, D. R., Peck, K. R., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04865-14 · Cited by 4
Krueger, W. A., Heininger, A., Grabein, B., Unertl, K. E., & García, M. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02313-13 · Cited by 3
Talan, D. A., Stamm, W. E., Hooton, T. M., Moran, G. J., Burke, T., Iravani, A., Reuning-Scherer, J., & Church, D. A. (2000) · JAMA · doi:10.1001/jama.283.12.1583
Cited by
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
Majumder, M. A. A., Rahman, S., Cohall, D., Bharatha, A., Singh, K., Haque, M., & Gittens-St Hilaire, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s290835 · Cited by 633
Motsch, J., Murta de Oliveira, C., Stus, V., Köksal, I., Lyulko, O., Boucher, H. W., Kaye, K. S., File, T. M., Brown, M. L., Khan, I., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz530 · Cited by 422
Boyd, S. E., Livermore, D. M., Hooper, D. C., & Hope, W. W. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00397-20 · Cited by 315
Self-citationMultidrug-resistant Gram-negative bacterial infections
Macesic, N., Uhlemann, A.-C., & Peleg, A. Y. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02081-6 · Cited by 315
Eze, E., Chenia, H., & El Zowalaty, M. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s169894 · Cited by 264
Metadata
- Authors
- Hawkey, P. M., Warren, R. E., Livermore, D. M., McNulty, C. A. M., Enoch, D. A., Otter, J. A., & Wilson, A. P. R.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-03-01
- Volume
- 73
- Issue
- suppl_3
- Pages
- iii2-iii78
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2793390003
- Cited by
- 334
- References
- 347
- FWCI
- 16.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.